Let’s stop pretending we don’t see it.
Healthcare executives didn’t quietly drift into astronomical pay—they engineered a system where the scoreboard measures everything except care. Somewhere along the way, the mission statement got mugged in a back alley and replaced with a balance sheet wearing a lab coat.
We are told healthcare is “too complex” for the public to understand—as if complexity itself is a moral shield. As if opacity is a virtue. As if the average patient staring at a five-figure bill for a two-hour visit just needs a better appreciation for “operational nuance.”
No. What they need is a flashlight.
Because here’s the absurdity: the people closest to patient care—nurses, physicians, technicians—are asked to do more with less, while those furthest from the bedside are rewarded as if they personally resuscitated the entire system.
Executives speak of “margin pressures” while approving compensation packages that look like private equity exit strategies. They talk about “efficiency” while building administrative empires with titles that require a glossary. Meanwhile, a patient is googling whether they can afford to follow up on a diagnosis.
And we’re just supposed to accept that?
We’re told high executive pay is necessary to attract “top talent.” Talent for what, exactly? Negotiating drug prices that somehow still vary wildly by zip code? Expanding square footage while shrinking trust? Perfecting the art of saying “patient-centered care” in a quarterly earnings call?
Let’s be honest: if this were truly a functioning market, the outcomes would reflect the incentives. But when the incentives reward financial growth over human outcomes, you don’t get innovation—you get distortion. You get a system where success is defined by revenue cycles, not recovery rates.
And here’s the kicker—much of this is happening under the banner of “non-profit.” Non-profit. Let that bounce around for a second. Organizations that enjoy tax advantages meant to serve communities are compensating leadership at levels indistinguishable from corporate giants. At what point does “competitive compensation” become “community extraction”?
This is not about villainizing individuals. It’s about interrogating a structure that has quietly normalized the gap between those who deliver care and those who monetize it.
Because transparency shouldn’t be controversial. If executive pay is justified, then show the math. Tie it to outcomes people actually care about: reduced medical debt, improved patient access, measurable community health gains. Not just EBITDA dressed up as altruism.
The public doesn’t need an MBA to understand fairness. They understand when the system feels tilted. They understand when trust erodes. And right now, trust is hemorrhaging faster than any financial metric being reported.
So yes—reexamine executive pay. Drag it into the daylight. Ask uncomfortable questions. Demand alignment between compensation and care.
Because if healthcare is truly about healing, then the system itself might be overdue for a diagnosis.